Fundraising FoxBioFrontier Partners, Inc.
Venture capitalTokyo · Series A–Late Stage · 15 people tracked
Find your way into BioFrontier Partners, Inc.
Sign up to see every warm intro you have to BioFrontier Partners, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioFrontier Partners, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
BioFrontier Partners, Inc. is a Japanese venture capital firm focused on supporting bio and life science related businesses.
Source: firm website, verified Oct 26, 2026.
Team · 15 people
from the firm's website & public directories
Frequently asked questions
- What stage does BioFrontier Partners, Inc. invest at?
- BioFrontier Partners, Inc. invests at the Series A, Series B, Series C, Late Stage stages.
- What is BioFrontier Partners, Inc.'s typical check size?
- BioFrontier Partners, Inc. typically writes checks of $500K – $3M.
- What sectors does BioFrontier Partners, Inc. focus on?
- BioFrontier Partners, Inc. focuses on Biotech, Medical Devices.
- Where is BioFrontier Partners, Inc. located?
- BioFrontier Partners, Inc. is headquartered in Tokyo, JP.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Kreos Capital is a growth debt provider financing high-growth technology and healthcare companies across Europe and Israel. Founded in 1998, it was acquired by BlackRock in August 2023 and now operates within BlackRock's Private Markets platform.
Menlo Ventures is an early-stage venture capital firm backing transformative technology companies, with a strong current emphasis on artificial intelligence across enterprise, healthcare, and consumer markets.